The Fershman Journal — Tomorrow's News Delivered Today
The Fershman Journal — Tomorrow's News Delivered Today
The Fershman Journal — Tomorrow's News Delivered Today
At The Fershman Journal, we provide insightful analysis and commentary on global markets and financial policies. Join us as we explore the strategies that drive business success.
At The Fershman Journal, we provide insightful analysis and commentary on global markets and financial policies. Join us as we explore the strategies that drive business success.
At The Fershman Journal, we provide insightful analysis and commentary on global markets and financial policies. Join us as we explore the strategies that drive business success.
Featured
Featured
Macro Risks
The Office Market’s New Reality
Apr 13, 2026
M&A and Restructuring
The Battle for Hollywood’s Crown Jewels
Apr 13, 2026
Consumer
A Bet on Hits, Not Streams
Apr 13, 2026
Tech
An AI Strategy in Search of a Business Model
Apr 7, 2026
Logistics & Supply Chains
Buying Scale at a Price
Apr 6, 2026
Forecasts & Scenarios
Why OneStream Traded Public Scrutiny for Hg’s Deep Pockets
Apr 4, 2026
M&A and Restructuring
An Analysis of the $58 Billion Devon-Coterra Mega-Merger
Apr 4, 2026
Healthcare
A Cure Too Risky to Buy?
Apr 1, 2026
Finance
Selling Banamex at a Discount
Mar 30, 2026
Consumer
Private Equity’s Sandwich Turnaround
Feb 18, 2026
Macro Risks
The Office Market’s New Reality
Diya Mangaraj
Apr 13, 2026
Post-pandemic shifts have broken the traditional real-estate cycle. Demand is no longer rebounding evenly, but concentrating in top-tier spaces, leaving weaker offices behind and forcing cities to rethink how to repurpose surplus supply.
M&A and Restructuring
The Battle for Hollywood’s Crown Jewels
Shaurya Vohra
Apr 13, 2026
Paramount’s victory over Netflix for Warner Bros. Discovery marks a defining moment in media consolidation. The deal promises scale and control over premium content—but now faces intense scrutiny over its implications for competition.
Consumer
A Bet on Hits, Not Streams
Samuel Regelman
Apr 13, 2026
In India’s booming but under-monetized music market, UMG is betting on global breakout hits. Without international success, even a steady pipeline of soundtracks may fail to justify the investment.
Tech
An AI Strategy in Search of a Business Model
Yessica Jain
Apr 7, 2026
Meta’s latest acquisition highlights a widening gap between ambition and execution. Despite heavy investment, the company has yet to define how AI will reshape its advertising-driven model or deliver meaningful returns.
Logistics & Supply Chains
Buying Scale at a Price
Safiia Mirgalimova
Apr 6, 2026
Hapag-Lloyd’s $4.2bn bid for ZIM highlights shipping’s relentless drive for scale. The deal promises stronger routes and cost synergies, but political tensions, falling revenues, and national-security concerns make its payoff far from certain.
Forecasts & Scenarios
Why OneStream Traded Public Scrutiny for Hg’s Deep Pockets
Adam Gurevich
Apr 4, 2026
Hg Capital’s $6.4bn take-private of OneStream exposes a market disconnect: public investors punished short-term losses, while private equity saw long-term dominance in CFO software. What looked like weakness became a bargain for patient capital.
M&A and Restructuring
An Analysis of the $58 Billion Devon-Coterra Mega-Merger
Judy Lin
Apr 4, 2026
Devon Energy and Coterra Energy have merged in a $58B deal, which highlights the “mega-independent” trend in U.S. shale amidst a rising demand for natural gas to power AI data centers and LNG exports.
Healthcare
A Cure Too Risky to Buy?
Cayden Liu
Apr 1, 2026
Merck’s decision to walk away from Revolution Medicines highlights the tension between scientific promise and financial risk. In oncology, even breakthrough drugs carry uncertain returns, leaving firms to weigh billion-dollar bets against fragile probabilities.
Finance
Selling Banamex at a Discount
Diego Rosario
Mar 30, 2026
Citigroup’s planned divestment of Banamex reveals a stark valuation gap, with offers far below peers. A future IPO may recover value, but weak market depth, regulatory overhang and investor skepticism make the outcome far from certain.
Consumer
Private Equity’s Sandwich Turnaround
Dongji Dominic Zhang
Feb 18, 2026
Roark Capital’s $9.6bn takeover of Subway wagers that disciplined franchising, digital upgrades, and margin-focused innovation can revive a fading giant. Predictable royalties and heavy leverage offer upside, if franchisee trust and brand relevance can be restored.
Macro Risks
The Office Market’s New Reality
Diya Mangaraj
Apr 13, 2026
Post-pandemic shifts have broken the traditional real-estate cycle. Demand is no longer rebounding evenly, but concentrating in top-tier spaces, leaving weaker offices behind and forcing cities to rethink how to repurpose surplus supply.
M&A and Restructuring
The Battle for Hollywood’s Crown Jewels
Shaurya Vohra
Apr 13, 2026
Paramount’s victory over Netflix for Warner Bros. Discovery marks a defining moment in media consolidation. The deal promises scale and control over premium content—but now faces intense scrutiny over its implications for competition.
Consumer
A Bet on Hits, Not Streams
Samuel Regelman
Apr 13, 2026
In India’s booming but under-monetized music market, UMG is betting on global breakout hits. Without international success, even a steady pipeline of soundtracks may fail to justify the investment.
Tech
An AI Strategy in Search of a Business Model
Yessica Jain
Apr 7, 2026
Meta’s latest acquisition highlights a widening gap between ambition and execution. Despite heavy investment, the company has yet to define how AI will reshape its advertising-driven model or deliver meaningful returns.
Logistics & Supply Chains
Buying Scale at a Price
Safiia Mirgalimova
Apr 6, 2026
Hapag-Lloyd’s $4.2bn bid for ZIM highlights shipping’s relentless drive for scale. The deal promises stronger routes and cost synergies, but political tensions, falling revenues, and national-security concerns make its payoff far from certain.
Forecasts & Scenarios
Why OneStream Traded Public Scrutiny for Hg’s Deep Pockets
Adam Gurevich
Apr 4, 2026
Hg Capital’s $6.4bn take-private of OneStream exposes a market disconnect: public investors punished short-term losses, while private equity saw long-term dominance in CFO software. What looked like weakness became a bargain for patient capital.
M&A and Restructuring
An Analysis of the $58 Billion Devon-Coterra Mega-Merger
Judy Lin
Apr 4, 2026
Devon Energy and Coterra Energy have merged in a $58B deal, which highlights the “mega-independent” trend in U.S. shale amidst a rising demand for natural gas to power AI data centers and LNG exports.
Healthcare
A Cure Too Risky to Buy?
Cayden Liu
Apr 1, 2026
Merck’s decision to walk away from Revolution Medicines highlights the tension between scientific promise and financial risk. In oncology, even breakthrough drugs carry uncertain returns, leaving firms to weigh billion-dollar bets against fragile probabilities.
Finance
Selling Banamex at a Discount
Diego Rosario
Mar 30, 2026
Citigroup’s planned divestment of Banamex reveals a stark valuation gap, with offers far below peers. A future IPO may recover value, but weak market depth, regulatory overhang and investor skepticism make the outcome far from certain.
Consumer
Private Equity’s Sandwich Turnaround
Dongji Dominic Zhang
Feb 18, 2026
Roark Capital’s $9.6bn takeover of Subway wagers that disciplined franchising, digital upgrades, and margin-focused innovation can revive a fading giant. Predictable royalties and heavy leverage offer upside, if franchisee trust and brand relevance can be restored.
Big Read
Big Read
Latest Articles
Apr 13, 2026
Apr 13, 2026
Apr 13, 2026
Apr 7, 2026
Apr 6, 2026
Apr 1, 2026
Load More